Holen Sie sich die Stockscreener-App
7.65
1.19%
0.09
Handel nachbörslich:
7.65
Schlusskurs vom Vortag:
$7.56
Offen:
$7.58
24-Stunden-Volumen:
77,833
Relative Volume:
1.21
Marktkapitalisierung:
$202.66M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-28.87M
KGV:
-5.9579
EPS:
-1.284
Netto-Cashflow:
$-16.01M
1W Leistung:
+2.14%
1M Leistung:
-14.62%
6M Leistung:
+26.45%
1J Leistung:
-7.27%
1-Tages-Spanne:
$7.57
$7.88
1-Wochen-Bereich:
$7.44
$7.94
52-Wochen-Spanne:
$5.55
$11.52
Nuvectis Pharma Inc Stock (NVCT) Company Profile
Firmenname
Nuvectis Pharma Inc
Sektor
Branche
Telefon
360-837-7232
Adresse
1 BRIDGE PLAZA, SUITE 275, FORT LEE
Compare NVCT vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVCT
Nuvectis Pharma Inc
|
7.65 | 200.28M | 0 | -28.87M | -16.01M | -1.284 |
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.25 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.81 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Nuvectis Pharma Inc Stock (NVCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-02 | Eingeleitet | Maxim Group | Buy |
| 2025-03-17 | Eingeleitet | Laidlaw | Buy |
| 2022-07-13 | Eingeleitet | Ladenburg Thalmann | Buy |
Nuvectis Pharma Inc Aktie (NVCT) Neueste Nachrichten
Trading the Move, Not the Narrative: (NVCT) Edition - Stock Traders Daily
NVCT Stock Price, Quote & Chart | NUVECTIS PHARMA INC (NASDAQ:NVCT) - ChartMill
Nuvectis Pharma (NASDAQ:NVCT) Trading Down 1.7%Here's What Happened - marketbeat.com
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting - investingnews.com
Nuvectis to present NXP900 data at cancer research meeting By Investing.com - Investing.com Australia
Nuvectis Pharma announces upcoming presentations for NXP900 at the 2026 American Association for Cancer Research meeting - MarketScreener
Nuvectis Pharma schedules NXP900 presentations for 2026 American Association for Cancer Research event - Traders Union
Nuvectis to present NXP900 data at cancer research meeting - investing.com
NVCT Technical Analysis & Stock Price Forecast - Intellectia AI
(NVCT) Volatility Zones as Tactical Triggers - Stock Traders Daily
Here's Why We're Not Too Worried About Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Situation - Yahoo Finance
Aug Closing: Does Nuvectis Pharma Inc meet Warren Buffetts criteriaEarnings Trend Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
NVCT SEC FilingsNuvectis Pharma, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
NVCT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Price-Driven Insight from (NVCT) for Rule-Based Strategy - Stock Traders Daily
Aug Highlights: Can Nuvectis Pharma Inc maintain its current growth rate2026 Outlook & Reliable Trade Execution Plans - baoquankhu1.vn
Nuvectis Pharma (NASDAQ:NVCT) Shares Up 6.3%Still a Buy? - MarketBeat
Why retail investors pile into Nuvectis Pharma Inc. stock2025 Top Decliners & Risk Controlled Daily Trade Plans - Naître et grandir
(NVCT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
NVCT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
NVCT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
NVCT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
[EFFECT] Nuvectis Pharma, Inc. SEC Filing - Stock Titan
(NVCT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Nuvectis Pharma (NVCT) to Release Quarterly Earnings on Tuesday - Defense World
Is Nuvectis Pharma Inc. stock cheap at current valuationLayoff News & Smart Money Movement Alerts - mfd.ru
Is Nuvectis Pharma Inc. stock a smart buy before Fed meetingJuly 2025 Rallies & Free Accurate Trade Setup Notifications - mfd.ru
What are Nuvectis Pharma Inc.’s growth leversJuly 2025 Macro Moves & Entry Point Confirmation Alerts - mfd.ru
Nuvectis Pharma FY2026 EPS Estimate Cut by HC Wainwright - Defense World
Nuvectis Pharma Files $150 Million Mixed Shelf - marketscreener.com
Analysts Offer Insights on Healthcare Companies: Nuvectis Pharma (NVCT), Tenet Healthcare (THC) and Upstream Bio, Inc. (UPB) - The Globe and Mail
HC Wainwright Forecasts Weaker Earnings for Nuvectis Pharma - MarketBeat
HC Wainwright Comments on Nuvectis Pharma Q1 Earnings - Defense World
Can Nuvectis Pharma Inc. stock hit record highs againJuly 2025 PostEarnings & Entry Point Strategy Guides - mfd.ru
HC Wainwright Predicts Nuvectis Pharma Q1 Earnings - MarketBeat
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Nuvectis Pharma, Inc. reports 2025 financial results and business highlights - marketscreener.com
Can Nuvectis Pharma Inc. be recession proof2025 Performance Recap & Low Volatility Stock Suggestions - mfd.ru
Nuvectis Pharma, Inc. SEC 10-K Report - TradingView
Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights - The Manila Times
Risk Analysis: Does Nuvectis Pharma Inc. have a competitive edgeEarnings Miss & Precise Entry and Exit Recommendations - baoquankhu1.vn
Does Nuvectis Pharma Inc. stock trade at a discount to peers2025 Macro Impact & Community Consensus Stock Picks - mfd.ru
Investment Report: Is Nuvectis Pharma Inc attractive for institutional investorsJuly 2025 WrapUp & Smart Swing Trading Techniques - baoquankhu1.vn
(NVCT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Nuvectis Pharma (NASDAQ:NVCT) Trading Up 5.8%Should You Buy? - MarketBeat
Nuvectis Pharma (NASDAQ:NVCT) Trading Up 5.8% – Should You Buy? - Defense World
Is Nuvectis Pharma Inc. stock a buy on dipsQuarterly Growth Report & Real-Time Volume Spike Alerts - bollywoodhelpline.com
Will Nuvectis Pharma Inc. stock outperform value stocksInsider Selling & Precise Trade Entry Recommendations - bollywoodhelpline.com
Investment Report: Will Nuvectis Pharma Inc outperform tech stocksGold Moves & Safe Capital Growth Plans - baoquankhu1.vn
Energy Moves: Is Nuvectis Pharma Inc stock a good pick for beginnersRisk Management & Low Drawdown Trading Techniques - baoquankhu1.vn
Take Profit: Can Nuvectis Pharma Inc maintain its current growth rateBreakout Watch & Smart Allocation Stock Reports - baoquankhu1.vn
Finanzdaten der Nuvectis Pharma Inc-Aktie (NVCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):